Natural Products
Catalog No. | Information |
CFN93193 | Vinaginsenoside R4 Vinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound. |
CFN93188 | Plantainoside D Plantainoside D shows potent antioxidative effects as those of ascorbic acid, it shows angiotensin-converting enzyme (ACE) inhibitory inhibitory activity in vitro with the IC(50) value of 2.17 mM, it also shows inhibitory activity against PKCalpha with the IC50 value (in microM) of 14.8. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. |
CFN93186 | Licochalcone D Licochalcone D has anti-inflammatory, and anti-allergic activities, it shows suppression ability of nitric oxide (NO) production, it also suppresses degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells. Licochalcone D has cardioprotective potential against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts. It may be a potential drug for human melanoma treatment by inhibiting proliferation, inducing apoptosis via the mitochondrial pathway and blocking cell migration and invasion. |
CFN93163 | Jionoside D (Cistanoside C) Jionoside D exhibits antioxidant property. |
CFN93125 | Lucidenic acid E Reference standards. |
CFN93124 | 14,15beta-Dihydroxyklaineanone 14,15beta-Dihydroxyklaineanone is a plant growth inhibitor. It (IC(50) = 5 microM) shows anti-tumor promoting on tumor promoter-induced Epstein-Barr virus activation. |
CFN93119 | Brusatol Brusatol, a Nrf2 inhibitor, has dual anti-hepatitis C virus and anticancer effects and can enhance the comparable effects of sorafenib. Brusatol-mediated inhibition of c-Myc/ROS signaling pathway increases HIF-1α degradation by promoting PHD activity and induces cell death in colorectal cancer under hypoxia. It inhibits the response of cultured beta-cells to pro-inflammatory cytokines in vitro. Brusatol also shows antitrypanosomal activity against trypomastigotes of Trypanosoma evansi. |
CFN93097 | Melittoside Melittoside may have antioxidant activity. |
CFN93080 | Nortracheloside Reference standards. |
CFN93076 | Bacopaside I Bacopaside I is a modulator of Aquaporin-1 channel, has neuroprotective functions, it has anti-Alzheimer's disease, it ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid. Bacopaside I also exhibits an obvious antidepressant-like effect in mouse model of CUMS-induced depression that was mediated, at least in part, by modulating HPA hyperactivity and activating BDNF signaling pathway. |
CFN95073 | Dihydrolicoisoflavone Dihydrolicoisoflavone A possesses weaker anti-H. pylori activity, it may be useful chemopreventive agents for peptic ulcer or gastric cancer in H. pylori-infected individuals. |
CFN95072 | Licoarylcoumarin Licoarylcoumarin is a strong inhibitor of adenosine 3',5'-cyclic monophosphate (cAMP) phosphodiesterase. Licoarylcoumarin has antibacterial effects on the VRE strains; it has anti-HIV activity, and it has inhibitory effects on xanthine oxidase. |
CFN93034 | Lotusine Lotusine has antihypertension and antibacterial activities. |
CFN93031 | Laetanine Reference standards. |
CFN95071 | Suspenoidside B Suspenoidside B possesses strong hepatoprotective activities against the damage in HepG2 cell. |
CFN95070 | 7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin 7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells. |
CFN95069 | Lappaol F 1. Lappaol F has antioxidant and antiaging properties, it may promote the C. elegans longevity and stress resistance through a JNK-1-DAF-16 cascade. 2. Lappaol F has potential chemosensitizing activity, it may be candidates for developing novel adjuvant anticancer agents. 3. Lappaol F exhibits antitumor activity in vitro and in vivo and has strong potential to be developed as an anticancer therapeutic. 4. Lappaol F strongly inhibited NO production in the LPS-stimulated RAW264.7 cells with the IC(50) value of 9.5 microM. |
CFN95068 | Lappaol C Lappaol C has antioxidant and antiaging properties, it may promote the C. elegans longevity and stress resistance through a JNK-1-DAF-16 cascade. Lappaol C also has potential chemosensitizing activity, it may be candidates for developing novel adjuvant anticancer agents. |
CFN95067 | Lappaol A Lappaol A has antioxidant and antiaging properties, it may promote the C. elegans longevity and stress resistance through a JNK-1-DAF-16 cascade. Lappaol A also has potential chemosensitizing activity, it may be candidates for developing novel adjuvant anticancer agents. |
CFN95066 | Gancaonin N Reference standards. |
CFN95065 | Glyasperin C Glyasperin C acts as a partial estrogen antagonist, it shows tyrosinase inhibitory activity (IC (50) = 0.13 +/- 0.01 microg/mL), it could be a promising candidate in the design of skin-whitening agents. Glyasperin C shows potent anti-vancomycin-resistant Enterococci effects (MIC 1.9 × 10-5-4.5 × 10-5 M for E. faecium and E. faecalis). |
CFN95064 | Clemastanin B Clemastanin B has antioxidant and anti-inflammatory activities, it exerts its anti-influenza activity by inhibiting the virus multiplication, prophylaxsis and blocking the virus attachment. |
CFN95063 | Glicoricone Glicoricone acts as a partial estrogen antagonist. Glicoricone inhibited the monoamine oxidase with the IC50 values of 6.0 x 10(-5)-1.4 x 10(-4) M. |
CFN95062 | 3-Methoxyshancigusin I Reference standards. |
CFN95061 | Shancigusin I Shancigusin I is a natural from Cremastra appendiculata. |
CFN95060 | Angelol M Angelol M shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells. |
CFN95059 | Lucidumol A Lucidumol A has relatively good effect against aldose reductase with IC50 of 19.1uM. Lucidumol A has cytotoxic activity, it reduced cell growth in three human carcinoma cells (Caco-2, HepG2, and HeLa cells) dose dependently with LC50s from 20.87 to 84.36 uM. |
CFN95058 | Methyl lucidenate G Reference standards. |
CFN95057 | 3''-O-Galloylmyricitrin Reference standards. |
CFN95056 | Poricoic acid G Poricoic acid G shows inhibition of tumor-promoting effects and cytotoxic activity. |
CFN95055 | Lonicerin Lonicerin has antioxidant, anti-arthritic and antifungal activities, it can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection. |
CFN95054 | Obovatol Obovatol has antioxidant, neuroprotective, antiinflammatory, antithrombotic and antitumour effects, it is a potent NF-κB inhibitors for Alzheimer's disease treatment. Obovatol shows inhibitory effect on the Salmonella type III secretion system, it could be useful for the prevention and supplementary treatment of bacterial infections. Obovatol inhibits receptor activator of nuclear factor kappa B (NF-κB) ligand (RANKL)-induced osteoclast differentiation in vitro and inflammatory bone loss in vivo, it may be a useful therapeutic agent for the treatment of pathological bone disorders characterized by excessive osteoclastic bone resorption. |
CFN95053 | 1-O-galloyl-6-O-cinnamoylglucose Reference standards. |
CFN95052 | Kakkalide Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects. Kakkalide can inhibit ROS-associated inflammation and ameliorated insulin-resistant endothelial dysfunction by beneficial effects on IRS-1 function.Kakkalide attenuates ethanol-induced gastric injury in mice by inhibiting the infiltration of neutrophils, it also shows protective effects on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. |
CFN95051 | Tectoruside Tectoruside is a natural product from Iris tectorum. |
CFN95050 | Poricoic acid B Poricoic acid B shows inhibitory activity against TPA-induced ear inflammatory oedema, it also shows potent inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). |
CFN95049 | Arjunglucoside I Arjunglucoside I has anti-inflammatory activity, it exhibits significant activity against carrageenan-induced paw edema in rat. It also shows antiproliferative activity against the A2780 human ovarian cancer cell line with an IC(50) value of 1.2 microM. |
CFN95048 | 3''-Galloylquercitrin 1. 3''-Galloylquercitrin possesses the activity for PTK inhibition. |
CFN95047 | Betmidin Reference standards. |
CFN95046 | 2''-O-Galloylmyricitrin Reference standards. |
CFN95045 | Carasiphenol C Carasiphenol C is a natural product from Carex humilis Leyss. |
CFN95044 | Carasinol D Carasinol D is a natural product from Carex humilis Leyss. |
CFN95043 | 1,3,6-Tri-O-galloylglucose 1,3,6-Tri-O-galloylglucose shows anti-inflammatory activity. |
CFN95042 | Carasinol B Carasinol B is a natural product from Carex humilis Leyss. |
CFN95041 | 2''-O-Galloylquercitrin 2''-O-Galloylquercitrin is a natural product from Acer ginnala. |
CFN95040 | Cordifolioside A Cordifolioside A possesses immunomodulatory activity, it has a potential in vivo radioprotective effect as well as in vitro cytoprotective activity. |
CFN95039 | Arjungenin Arjungenin shows β-glucuronidase inhibitory activity, it shows antiviral, and anti-inflammatory activities. Arjungenin exhibits moderate antibacterial activity against Staphylococcus aureus, Escherichia coli and Enterococcus faecalis (MICs within a range of 64 and 256 ug/mL). Arjungenin shows significant protection against domoic acid induced toxicity in Caco-2 cell line. |
CFN95038 | Columbianetin beta-D-glucopyranoside Columbianetin-beta-D-glucopyranoside exhibits anti-inflammatory and analgesic properties, it also shows strong inhibiting activity against platelet aggregation. |
CFN95037 | Iristectorin A Iristectorin A is a natural product from Iris tectorum. |
CFN95036 | 20-O-Glucoginsenoside Rf 20-O-Glucoginsenoside Rf is a natural product from Panax ginseng C. A. Mey. |